Boxer Capital, LLC Intercept Pharmaceuticals, Inc. Transaction History

Boxer Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $28.8 Million - $49.9 Million	-1,176,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $41 Million - $56.1 Million	1,050,000 Added 833.33%	1,176,000 $48.8 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $5.88 Million - $11.6 Million	126,000 New	126,000 $6.04 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $55.1 Million - $72.4 Million	-600,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $51.5 Million - $75.9 Million	600,000 New	600,000 $60.5 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.